Professor of Translational Chemistry
University of Edinburgh, UK
Our research group develops chemical agents for photodynamic therapy of glioblastoma. We have invented one of the smallest family of photosensitizers ever reported. These photosensitizers can be coupled to metabolites that can target cancer cells with high selectivity. In collaboration with experts in brain cancer biology and neurosurgery, we are working to translate these new agents for future applications in brain cancer surgery.
Existing collaborations relevant to drug delivery
Publications relevant to drug delivery
Benson S, de Moliner F, Fernandez A, et al (2021) Photoactivatable metabolic warheads enable precise and safe ablation of target cells in vivo. Nat Commun. Apr 22;12(1):2369. doi: 10.1038/s41467-021-22578-2
Vendrell et al. Small molecule photosensitizers for photodynamic therapy. WO 2020/187913.
Email for contact details